๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase I study of the combination of benznidazole and CCNU in man

โœ Scribed by J.T. Roberts; N.M. Bleehen; F.Y.F. Lee; P. Workman; M.I. Walton

Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
441 KB
Volume
10
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I-II study of ftorafur and methyl-
Phase I-II study of ftorafur and methyl-ccnu in advanced colorectal cancer
โœ Robert J. Belt; Ronald Stephens ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 316 KB ๐Ÿ‘ 2 views

The combination of Ftorafur (NSC-148958) and methyl-CCNU (NSC-95441) was evaluated in 36 patients with advanced colorectal cancer. The principle toxicities encountered were myelosuppression, gastrointestinal, and neurological. There were no complete responses and only 5/34 (14.7%) patients achieved

A phase II study of intravenously-admini
A phase II study of intravenously-administered methyl CCNU in the treatment of advanced sarcomas
โœ Paul Chang; Marshall A. Levine; Peter H. Wiernik; Michael D. Walker ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB ๐Ÿ‘ 2 views

Thirty-two patients with advanced, inoperable nonhematologic soft-tissue and osseous sarcomas were treated with Methyl CCNU administered via controlled intravenous infusion in doses of 130-170 mg/m2 every 6 weeks in a Phase I1 trial. All 28 evaluable patients were no longer responsive to adriamycin.